Low incidence of congenital toxoplasmosis in children born to women infected with human immunodeficiency virus

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 68, Issue 1-2, 1996, Pages 93-96

  Giaquinto, C ^l   Grosch Worner I ^a   Mok, Jacqui ^b   Omenaca Teres F ^c   Martinez Zapico, R ^l   Bates, I ^l   Hawkins, F ^l   Canosa, C A ^d   Scherpbier, H ^e   Bohlin, A B ^f   Forsgren, M ^f   Levy, J ^g   Alimenti, A ^g   Ferrazin, A ^h   De Maria, A ^h   Gotta, C ^h   Mur A ⁱ   Dunn, David ^j   Newell, Marie Louise ^j   Gilbert, Ruth ^j   Petersen, Eskild ^k   Peckham, Catherine ^j   more..

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CITY HOSPITAL   (United Kingdom)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ HOSPITAL DEL MAR   (Spain)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

^k STATENS SERUM INSTITUT   (Denmark)

^l Statens Seruminstitut ^*

more..

Author keywords

Congenital toxoplasmosis; HIV infection; Prophylaxis; Reactivation

Indexed keywords

ARTICLE; CONGENITAL TOXOPLASMOSIS; FETUS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFANT; MAJOR CLINICAL STUDY; PARASITE TRANSMISSION; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR;

EID: 0030248922     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-2115(96)02497-9     Document Type: Article

References (18)

1. [1] Hall SM. Congenital toxoplasmosis. Br Med J 1992; 305: 291-297.
2. [2] Holliman RE. Clinical sequelae of chronic maternal Toxoplasmosis. Rev Med Microbiol 1994; 5: 47-55.
3. [3] Carr A, Tindall B, Brew BJ, et al. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Inter Med 1992; 117: 106-111.
4. [4] Zufferey J, Sugar A, Rudaz P, Bille J, Glauser MP, Chave JP. Prevalence of latent toxoplasmosis and serological diagnosis of active infection in HIV-positive patients. Eur J Clin Microbiol Infect Dis 1993; 12: 591-595.
5. [5] Mitchell CD, Erlich SS, Mastrucci MT, Hutto SC, Parks WP, Scott GB. Congenital toxoplasmosis occuring in infants perinatally infected with human immunodeficiency virus 1. Pediatr Infect Dis J 1990; 9: 512-518.
6. [6] Marty P, Bongain A, Rahal A, Thulliez P, Wasfi D, Lambert JC, Le Fichoux Y, Gillet JY. Prenatal diagnosis of severe fetal toxoplasmosis as a result of toxoplasmic reactivation in an HIV-1 seropositive woman. Prenatal Diagnosis 1994; 14: 414-415.
7. [7] Dubey JP, Beattie CP. Toxoplasmosis of animals and man. CRC Press, Florida, 1988; p 45-46.
8. [8] European Centre for the Epidemiotogical Monitoring of AIDS. AIDS Surveillance in Europe. Quarterly Report number 44: 31 December 1994.
9. [9] European Collaborative Study. Natural history of vertically acquired human immunodeficiency virus-1 infection. Pediatr 1994; 94: 815-819.
10. [10] Alford CA, Stagno S, Reynolds DW. Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease. Bull New York Acad Med 1974; 50: 160-181.
11. [11] Hanley JA, Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 1983; 13; 1743-1745.
12. [12] European Collaborative Study. Age-related standards for T lymphocyte subsets based on uninfected children born to human immunodeficiency virus 1-infected women. Pediatr Infect Dis J 1992; 11: 1018-1026.
13. [13] Grossman PL, Remington JS. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo. Am J Trop Med Hyg 1979; 28: 445-455.
14. [14] Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992; 327: 1643-1648.
15. [15] Frenkel JK, Escajadillo A. Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis. Am J Trop Med Hyg 1987; 36: 517-522.
16. [16] Connelly RT, Lourwood DL. Pneumocystis carinii pneumonia prophylaxis during pregnancy. Pharmacotherapy 1994; 14: 424-449.
17. [17] Jeannel D, Costagliola D, Niel G, Hubert B, Danis M. What is known about the prevention of congenital toxoplasmosis? Lancet 1990; 336: 359-361.
18. [18] Thorne C, Newell ML, Dunn D, Peckham C. The European Collaborative Study: clinical and immunological characteristics of HIV 1-infected pregnant women. Br J Obstet Gynaecol 1995; 102: 869-875.